← Open Payments lookup

LYNN CHUONG: Open Payments

NPI 1386359511 · LIVE OAK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,055 in 166 payments from 20 companies in 2025. Trend: 2023 $2,220 · 2024 $3,003 · 2025 $3,055

Food & beverage: $2,970Education: $85
CompanyPaymentsAmount
ABBVIE INC.32$624
Madrigal Pharmaceuticals18$396
Janssen Biotech, Inc.22$395
Takeda Pharmaceuticals U.S.A., Inc.14$295
Salix Pharmaceuticals, a division of Bausch Health US, LLC15$263
Ardelyx, Inc.9$178
Ipsen Biopharmaceuticals, Inc15$168
Celltrion USA Inc.7$153
Lilly USA, LLC6$118
Gilead Sciences, Inc.5$105

Products named: REZDIFFRA, TREMFYA, RINVOQ, XIFAXAN, IBSRELA, IQIRVO, VEGZELMA, ENTYVIO.

Industry payments across TX — which companies pay providers there.